These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
249 related articles for article (PubMed ID: 27344013)
21. Ubiquitination and degradation of the thrombopoietin receptor c-Mpl. Saur SJ; Sangkhae V; Geddis AE; Kaushansky K; Hitchcock IS Blood; 2010 Feb; 115(6):1254-63. PubMed ID: 19880496 [TBL] [Abstract][Full Text] [Related]
22. Interaction of thrombopoietin with the platelet c-mpl receptor in plasma: binding, internalization, stability and pharmacokinetics. Li J; Xia Y; Kuter DJ Br J Haematol; 1999 Aug; 106(2):345-56. PubMed ID: 10460590 [TBL] [Abstract][Full Text] [Related]
23. Thrombopoietin receptor agonist antibody for treating chemotherapy-induced thrombocytopenia. Shin J; Kim MJ; Quan X; Kim JW; Lee S; Park S; Jeong JY; Yea K BMC Cancer; 2023 May; 23(1):490. PubMed ID: 37259024 [TBL] [Abstract][Full Text] [Related]
24. Humanized VB22B minibody for human Mpl stimulates human megakaryopoiesis but does not enhance platelet aggregation. Matsuki E; Miyakawa Y; Yamane A; Okamoto S Exp Hematol; 2011 Aug; 39(8):829-36. PubMed ID: 21605620 [TBL] [Abstract][Full Text] [Related]
25. Thrombopoietin and the c-Mpl receptor: insights from gene targeting. Alexander WS Int J Biochem Cell Biol; 1999 Oct; 31(10):1027-35. PubMed ID: 10582337 [TBL] [Abstract][Full Text] [Related]
26. The residual megakaryocyte and platelet production in c-mpl-deficient mice is not dependent on the actions of interleukin-6, interleukin-11, or leukemia inhibitory factor. Gainsford T; Nandurkar H; Metcalf D; Robb L; Begley CG; Alexander WS Blood; 2000 Jan; 95(2):528-34. PubMed ID: 10627458 [TBL] [Abstract][Full Text] [Related]
27. C-Cbl regulates c-MPL receptor trafficking and its internalization. Märklin M; Tandler C; Kopp HG; Hoehn KL; Quintanilla-Martinez L; Borst O; Müller MR; Saur SJ J Cell Mol Med; 2020 Nov; 24(21):12491-12503. PubMed ID: 32954656 [TBL] [Abstract][Full Text] [Related]
29. Cytokine production and function in c-mpl-deficient mice: no physiologic role for interleukin-3 in residual megakaryocyte and platelet production. Gainsford T; Roberts AW; Kimura S; Metcalf D; Dranoff G; Mulligan RC; Begley CG; Robb L; Alexander WS Blood; 1998 Apr; 91(8):2745-52. PubMed ID: 9531584 [TBL] [Abstract][Full Text] [Related]
30. Thrombopoietin stimulates colony-forming unit-megakaryocyte proliferation and megakaryocyte maturation independently of cytokines that signal through the gp130 receptor subunit. Broudy VC; Lin NL; Fox N; Taga T; Saito M; Kaushansky K Blood; 1996 Sep; 88(6):2026-32. PubMed ID: 8822921 [TBL] [Abstract][Full Text] [Related]
31. c-mpl, the thrombopoietin receptor. Vainchenker W; Methia N; Debili N; Titeux M; Wendling F Thromb Haemost; 1995 Jul; 74(1):526-8. PubMed ID: 8578519 [TBL] [Abstract][Full Text] [Related]
32. [Megakaryopoiesis: regulation of platelet production by thrombopoietin]. Vainchenker W; Besancenot R; Favale F Bull Acad Natl Med; 2013 Feb; 197(2):395-406. PubMed ID: 24919369 [TBL] [Abstract][Full Text] [Related]
33. Thrombopoietin does not induce lineage-restricted commitment of Mpl-R expressing pluripotent progenitors but permits their complete erythroid and megakaryocytic differentiation. Goncalves F; Lacout C; Villeval JL; Wendling F; Vainchenker W; Dumenil D Blood; 1997 May; 89(10):3544-53. PubMed ID: 9160659 [TBL] [Abstract][Full Text] [Related]
34. Regulation of hematopoietic stem cells by their mature progeny. de Graaf CA; Kauppi M; Baldwin T; Hyland CD; Metcalf D; Willson TA; Carpinelli MR; Smyth GK; Alexander WS; Hilton DJ Proc Natl Acad Sci U S A; 2010 Dec; 107(50):21689-94. PubMed ID: 21115812 [TBL] [Abstract][Full Text] [Related]
35. Functional characterization of c-Mpl ectodomain mutations that underlie congenital amegakaryocytic thrombocytopenia. Varghese LN; Zhang JG; Young SN; Willson TA; Alexander WS; Nicola NA; Babon JJ; Murphy JM Growth Factors; 2014 Feb; 32(1):18-26. PubMed ID: 24438083 [TBL] [Abstract][Full Text] [Related]
36. Studies of the c-Mpl thrombopoietin receptor through gene disruption and activation. Alexander WS; Roberts AW; Maurer AB; Nicola NA; Dunn AR; Metcalf D Stem Cells; 1996; 14 Suppl 1():124-32. PubMed ID: 11012212 [TBL] [Abstract][Full Text] [Related]
37. Thrombocytopenic c-mpl(-/-) mice can produce a normal level of platelets after administration of 5-fluorouracil: the effect of age on the response. Levin J; Cocault L; Demerens C; Challier C; Pauchard M; Caen J; Souyri M Blood; 2001 Aug; 98(4):1019-27. PubMed ID: 11493447 [TBL] [Abstract][Full Text] [Related]
38. Regulation of thrombopoietin levels by c-mpl-mediated binding to platelets. Fielder PJ; Gurney AL; Stefanich E; Marian M; Moore MW; Carver-Moore K; de Sauvage FJ Blood; 1996 Mar; 87(6):2154-61. PubMed ID: 8630374 [TBL] [Abstract][Full Text] [Related]
39. Targeting a thrombopoietin-independent strategy in the discovery of a novel inducer of megakaryocytopoiesis, DMAG, for the treatment of thrombocytopenia. Wang L; Liu S; Luo J; Mo Q; Ran M; Zhang T; Li X; Zou W; Mei Q; Chen J; Yang J; Zeng J; Huang F; Wu A; Zhang C; Wu J Haematologica; 2023 May; 108(5):1394-1411. PubMed ID: 36546424 [TBL] [Abstract][Full Text] [Related]
40. Low levels of erythroid and myeloid progenitors in thrombopoietin-and c-mpl-deficient mice. Carver-Moore K; Broxmeyer HE; Luoh SM; Cooper S; Peng J; Burstein SA; Moore MW; de Sauvage FJ Blood; 1996 Aug; 88(3):803-8. PubMed ID: 8704234 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]